Caplight Directory>Investors>Taiho Ventures>Taihoventures


Taiho Ventures

Taiho Ventures

Menlo Park, Californiataihoventures.com

Overview

Taiho Ventures, LLC is the corporate venture arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology . With $400M under management, they actively invest in early-stage private companies strategically relevant to Taiho Pharmaceutical . They consider company creation, spinouts and the option-type of investments as well as pure equity investments .

Year Founded

2016

AUM

$400M

Portfolio Companies

22

Investments

CompanyDateStageLead
Signadori BioMay 2026SeedCo-investor
Storm TherapeuticsApr 2026Series CCo-investor
CrossbowMar 2026Series BLead
CrossballMar 2026Series BLead
EpiBiologicsJan 2026Series BCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMenlo Park, California
Year Founded2016
AUM$400M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.